ASSOCIATED PRESS (AP) | For decades, bacteria have been figuring out how to resist the effects of antibiotics and at the same time, fewer drug makers are developing new antibiotics. Kevin Outterson talks about how CARB-X is funding innovative research to develop new antibiotics, vaccines and rapid diagnostics.